University of Alabama at Birmingham School of Medicine, Division of Hematology and Oncology is a clinical research site located in Birmingham, Alabama, United States 35233.
Crixeo Health Trust Score: 47/100 (POOR). This profile has not yet been claimed by the site owner.
University of Alabama at Birmingham School of Medicine, Division of Hematology and Oncology has participated in 1 clinical trials.
Therapeutic areas: Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis.
Sponsors: Kartos Therapeutics, Inc..
Trust Score: 47/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Alabama at Birmingham School of Medicine, Division of Hematology and Oncology has a Crixeo Trust Score of 47/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Alabama at Birmingham School of Medicine, Division of Hematology and Oncology has 1 clinical trials on record. Their work covers Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis.
University of Alabama at Birmingham School of Medicine, Division of Hematology and Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.